{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:29:31Z","timestamp":1790944171914,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.healun.2009.02.009","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T05:22:00Z","timestamp":1241500920000},"page":"461-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Prophylaxis Versus Preemptive Anti-cytomegalovirus Approach for Prevention of Allograft Vasculopathy in Heart Transplant Recipients"],"prefix":"10.1016","volume":"28","author":[{"given":"Luciano","family":"Potena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Musuraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ortolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Coccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fallani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Branzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2009.02.009_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2008.06.017","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report\u20142008","volume":"27","author":"Taylor","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.TP.0000080981.90718.EB","article-title":"Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant \u201catheroma.\u201d","volume":"76","author":"Valantine","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2009.02.009_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1600-6143.2006.01314.x","article-title":"Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy","volume":"6","author":"Mehra","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1462-5822.2004.00425.x","article-title":"Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system","volume":"6","author":"Mocarski","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.healun.2009.02.009_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jcv.2005.11.007","article-title":"Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease?","volume":"35","author":"Stassen","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.healun.2009.02.009_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.105.607549","article-title":"T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease","volume":"114","author":"Tu","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.02.009_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2009.02.009_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in Solid Organ Transplantation final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/rmv.513","article-title":"Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy","volume":"16","author":"Singh","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.healun.2009.02.009_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/rmv.514","article-title":"The case for cytomegalovirus prophylaxis in solid organ transplantation","volume":"16","author":"Snydman","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.healun.2009.02.009_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2009.02.009_bib12","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/QCO.0b013e328259c33b","article-title":"Cytomegalovirus-associated allograft rejection in heart transplant patients","volume":"20","author":"Potena","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.healun.2009.02.009_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000229039.87735.76","article-title":"Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection","volume":"82","author":"Potena","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2009.02.009_bib17","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","article-title":"Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years","volume":"45","author":"Kobashigawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2009.02.009_bib18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jacc.2004.12.076","article-title":"Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation","volume":"45","author":"Tuzcu","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2009.02.009_bib19","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1161\/01.CIR.92.12.3445","article-title":"Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation","volume":"92","author":"Rickenbacher","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.02.009_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1053-2498(03)00210-9","article-title":"First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation","volume":"22","author":"Kobashigawa","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1600-6143.2006.01297.x","article-title":"Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.healun.2008.02.016","article-title":"Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin","volume":"27","author":"Zhang","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2009.02.009_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl 10","key":"10.1016\/j.healun.2009.02.009_bib25","first-page":"51","article-title":"Cytomegalovirus","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.TP.0000054231.42217.A5","article-title":"Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study","volume":"75","author":"Potena","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2009.02.009_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib28","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection","volume":"8","author":"Billingham","year":"1990","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib29","doi-asserted-by":"crossref","first-page":"III-222","DOI":"10.1161\/circ.102.suppl_3.III-222","article-title":"Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy","volume":"102","author":"Caforio","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.02.009_bib30","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2009.02.009_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jacc.2007.03.055","article-title":"A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis","volume":"50","author":"Erglis","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2009.02.009_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.healun.2007.01.020","article-title":"Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation","volume":"26","author":"Biadi","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.02.009_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.ATV.0000120376.09047.fe","article-title":"Expansive arterial remodeling: location, location, location","volume":"24","author":"Pasterkamp","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2009.02.009_bib34","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.tp.0000256335.84363.9b","article-title":"Changes in coronary arterial dimensions early after cardiac transplantation","volume":"83","author":"Fearon","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2009.02.009_bib35","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.105.585703","article-title":"Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial","volume":"113","author":"Schoenhagen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.02.009_bib36","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.tp.0000230378.61437.a5","article-title":"Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy","volume":"82","author":"Bae","year":"2006","journal-title":"Transplantation"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249809001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249809001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:18:10Z","timestamp":1760948290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249809001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1053249809001193"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2009.02.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1161133.621604","asserted-by":"object"}]},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylaxis Versus Preemptive Anti-cytomegalovirus Approach for Prevention of Allograft Vasculopathy in Heart Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2009.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}